Search results
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
AOL· 4 days agoFood and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed ...
Health department encourages Baltimore residents to get vaccinated in new COVID-19 ads
WBFF Fox45 Baltimore· 12 hours agoWith travel season beginning, appointments for vaccinations can conveniently be scheduled at ...
4 ways vaccine skeptics mislead you on measles and more
The Columbian· 4 days agoMeasles is on the rise in the United States. In the first quarter of this year ...
US FDA approves Moderna’s RSV vaccine, its second marketed product
WHTC 1450 Holland· 4 days agoBy Patrick Wingrove (Reuters) - The U.S. Food and Drug Administration has approved Moderna's...
The new technology inside COVID-19 vaccines— mRNA
KRGV Rio Grande Valley· 2 days agoWhen you think of vaccines, you may think about traditional vaccines with weak or inactive parts of a virus to trigger an immune response. Today...
New COVID subvariants are rising: How bad will California get hit this summer?
LA Times via Yahoo News· 4 days agoLast summer's COVID wave in California was big enough to cause significant disruptions. As a new...
Attacks on Fauci Over Social Distancing and Masking Ignore the Science of Viral Spread
Scientific American· 10 hours agoAt this week’s House subcommittee hearing on COVID, Representative Marjorie Taylor Greene of Georgia...
COVID-19 summer surge on the horizon? What Ohio experts say about FLiRT and other variants
The Enquirer via Yahoo News· 2 days agoWhile Ohio's recorded COVID-19 numbers are at pandemic-inception level lows, the virus is here to stay for the foreseeable ...
More than 90% of chickenpox cases in New York City outbreak among unvaccinated people
ABC News via Yahoo News· 5 days agoNearly all the patients affected by an ongoing chickenpox outbreak in New York City are...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 5 days agoThe current COVID-19 boosters targeting the Omicron XBB.1.5 subvariant are still offering solid...